AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 1.1 Usage
Description: Participants will use their Radicle Clarity Active Study Product 1.1 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 2.1 Usage
Description: Participants will use their Radicle Clarity Active Study Product 2.1 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 3.1 Usage
Description: Participants will use their Radicle Clarity Active Study Product 3.1 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 4.1 Usage
Description: Participants will use their Radicle Clarity Active Study Product 4.1 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 4.2 Usage
Description: Participants will use their Radicle Clarity Active Study Product 4.2 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 4.3 Usage
Description: Participants will use their Radicle Clarity Active Study Product 4.3 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 1
Description: Participants will use their Placebo Control Form 1 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 2
Description: Participants will use their Placebo Control Form 2 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 3
Description: Participants will use their Placebo Control Form 3 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 4
Description: Participants will use their Placebo Control Form 4 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 5
Description: Participants will use their Placebo Control Form 5 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 5.1 Usage
Description: Participants will use their Radicle Clarity Active Study Product 5.1 as directed for a period of 6 weeks.
Study NCT05652725 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Clarity Active Study Product 5.2 Usage
Description: Participants will use their Radicle Clarity Active Study Product 5.2 as directed for a period of 6 weeks.
Study NCT04969757 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Predigraft group
Description: Patients in the interventional arm will use Predigraft (Class 1 medical device under MDD 93/42/EEC Cibiltech Society) to receive therapeutic education content (videos, facts sheets, short messages, questionnaires), exchange documents with their doctors and interact via messaging with them.~Physicians will be able to calculate their iBox score to predict their patients' allograft survival at 3, 5 and 7 years.
Study NCT05350137 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 100% oxygen
Description: During one-lung ventilation with an open chest, the non-ventilated lung collapses initially due to the inherent elastic recoil properties of the lung. Once passive venting has ceased, further collapse will then be wholly dependent on ongoing gaseous uptake and absorption atelectasis. Improved inflation-deflation method is currently the most widely used method in clinical practice. After dividing all the targeted vascular and bronchial structures, the lung of the operating side was re-inflated with 100% oxygen. After the operative lungs is completely expanded, perform pure oxygen mechanical single lung ventilation for the healthy lung, waiting for clear presentation of the plane between the targeted segment and the other segments.
Study NCT05350137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carbon dioxide
Description: During one-lung ventilation with an open chest, the non-ventilated lung collapses initially due to the inherent elastic recoil properties of the lung. Once passive venting has ceased, further collapse will then be wholly dependent on ongoing gaseous uptake and absorption atelectasis. The solubility coefficient for carbon dioxide is 0.57. The rapid diffusion properties of carbon dioxide would be expected to speed lung collapse and so facilitate surgery. After the targeted segment structures were successfully dissected, the collapsed intraoperative lung was completely re-expanded with carbon dioxide. After the operative lungs is completely expanded, perform pure oxygen mechanical single lung ventilation for the healthy lung, waiting for clear presentation of the plane between the targeted segment and the other segments.
Study NCT06323876 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HRCT
Description: High resolution computed tomography (HRCT) scan is a medical imaging technique used to obtain detailed internal images of the body. HRCT images will be obtained at 0 and 12 months.
Study NCT06323876 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Draw
Description: During blood draw, someone uses a needle to take blood from a vein, usually in your arm.
Study NCT05878730 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: urine collection
Description: * Urine collection will be made on a 12 hours period (20h00-8h00), the night before V2~* at V2 : 2 mL urinal sample for measure of 6-SMT concentration (ng/mL) and creatinin (mg/mL)~* Measure of 6-SMT will be made by a validated radio-immunology assay
Study NCT05878730 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Level of Proteins
Description: * blood sample at V2 (2x3.5mL citrate tubes)~* measured by ELISA
Study NCT05878730 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Level of mRNA and miRNA
Description: * blood sample at V2 (2x2.5mL PAX-gene tube)~* measured by quantitative RT-PCR
Study NCT05878730 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Level of plasmatic and intraerythrocytic lithium
Description: * blood sample at V2 (mmol/L)~* 4mL EDTA tube
Study NCT06302530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stayer
Description: In group A, the intervention involves using the Strayer technique, an echo-guided recession of the gastrocnemius tendon, with local anesthesia and sedation as needed. The patient can be in a prone or supine position. Ultrasound will identify the sural nerve and blood vessels to prevent damage. The entry point is 2-3 cm distal to the medial head of the gastrocnemius. Local anesthetic is infiltrated, and blunt dissection creates a working space. V-shaped curettes widen the entry point without harming noble structures.~Under direct ultrasound control, a curved scalpel is inserted until reaching the medial border of the gastrocnemius tendon. Transection occurs progressively from medial to lateral while flexing the foot. Verification of complete tendon transection is done with a blunt dissector. Finally, a dressing with adhesive strips and an elastic bandage is applied, eliminating the need for sutures.
Study NCT06302530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Plantar transection
Description: In group B, an echo-guided transection of the plantar tendon will be performed. Local anesthesia and sedation will be used as needed. The patient will be in prone or supine position. The plantar tendon will be identified ultrasonographically on the medial aspect of the gastrocnemius distal to the myotendinous junction. Local anesthetic will be infiltrated at that point to isolate the plantar tendon. An ultrasound-guided retrograde hook is introduced until the plantar tendon is engaged. Then proceed to retrograde transection of the tendon from lateral to medial, verifying complete section. At the end, a dressing with adhesive strips and elastic bandage, without sutures, will be performed.
Study NCT05275179 — intervention group
Intervention type: OTHER
Intervention: Posaconazole Therapeutic Drug Monitoring
Description: Therapeutic Drug Monitoring is performed by measuring posaconazole concentrations in serum on seven consecutive days (anticipated).
Study NCT04953234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NovoTTF-100L
Description: Patients receive continuous TTFields treatment using the NovoTTF-100L device. TTFields treatment will consist of wearing four electrically insulated electrode arrays on the thorax. The treatment enables the patient to maintain regular daily routine.
Study NCT04860804 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin and Ketamine
Description: Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin
Study NCT04860804 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral Ketamine
Description: Proprietary oral formulation of 0.5mg/kg of ketamine
Study NCT06436638 — intervention group
Intervention type: DEVICE
Intervention: Non-invasive ventilation support equipment
Description: Non-invasive ventilation support is provided by nasal airway and nasal CPAP mask to avoid respiratory complications such as hypoxia, desaturation, hypercarbia, respiratory depression etc. during extraction of impacted molars under deep sedation.
Study NCT05865691 — intervention group
Intervention type: OTHER
Intervention: biomarker assay
Description: blood sample on the day of inclusion
Study NCT04385173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B7-H3 CAR-T
Description: The B7-H3 CAR-T will be administrated via intratumoral or Intracerebroventricular injection through an Ommaya catheter in between Temozolomide cycles. Temozolomide will be stopped during the infusion of B7-H3 CAR-T
Study NCT04385173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Temozolomide will be given to patients orally every 5 days with 23 days interval. The initial dose is 150 mg/m2 on the first day and 200 mg/m2 for the rest if no toxicity is seen. If 200 mg/m2 is toxic, the drug will return to 150 mg/m2 or will be stopped.
Study NCT06548139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Natural full human monoclonal antibody CBB 1 injection 50.0µg/kg
Description: Active ingredient: natural full human monoclonal antibody CBB 1 containing 0.5 mg / ml per dose (2.5ml) Ingredients: 25 mM citrate buffer, 125 mM sodium chloride, 0.02% (w / v) polysorbate 20 and water for injection
Study NCT06548139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Natural full human monoclonal antibody CBB 1 injection 100.0µg/kg
Description: Active ingredient: natural full human monoclonal antibody CBB 1 containing 0.5 mg / ml per dose (2.5ml) Ingredients: 25 mM citrate buffer, 125 mM sodium chloride, 0.02% (w / v) polysorbate 20 and water for injection
Study NCT06548139 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabies Human Immunoglobulin (HRIG)
Description: Active ingredient: Rabid human immunoglobulin
Study NCT06548139 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lyophilized rabies vaccine for human use (Vero cells)
Description: Active ingredient: inactivated rabies virus fixed poison
Study NCT06548139 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Lyophilized rabies vaccine for human use (Vero cells)
Description: Active ingredient: inactivated rabies virus fixed poison
Study NCT05483829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adhera® Fatigue for Long COVID program
Description: Adhera® for the Long COVID program, which includes an application and a smartwatch, supported by digital health solution based on emotional and behavioral change techniques. Patient Adaptative Self-Management Content (e.g. psycho-educational content, activities for mental wellbeing, personalized motivational messages), and the personalization is based on Adhera® Health Recommender System.~Wearable devices and the mobile app will be used to collect real-time data for 4 weeks to detect biometric and psychometric (patient-reported outcomes) information.
Study NCT05357417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: utidelone
Description: 30mg/m2 (±10%), day 1-5 every 3-week cycle
Study NCT05357417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 15mg/kg, day 1
Study NCT04990817 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Average American Diet With SoFAS Replaced With Avocado
Description: Replacing energy from solid fats and added sugars (SoFAS) with Avocado as part of an average American diet
Study NCT04990817 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Average American Diet
Description: Average American diet based on macronutrient analyses from the most recent Nutrition and Health Examination Survey.
Study NCT06705595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tracheo-Spray
Description: Participants will receive 2 ml of 10% lidocaine delivered via a Tracheo-Spray device to the tracheal mucosa before anesthesia induction.
Study NCT06705595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Spray on DLT
Description: Before intubation, participants will receive 10% lidocaine spray applied to the distal surface and cuffs of the double-lumen tube (DLT).
Study NCT06705595 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Saline (Placebo)
Description: Before intubation, participants will receive 1 ml of 0.9% saline applied to the distal surface and cuffs of the double-lumen tube (DLT).
Study NCT06744907 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 10% Povidone-Iodine Arm
Description: A second application of surgical antisepsis with a topical povidone-iodine in the subdermal layer after making an incision.
Study NCT06744907 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Saline Arm
Description: An application of saline in the subdermal layer after making an incision.
Study NCT06751381 — intervention group
Intervention type: DEVICE
Intervention: IVIM Imaging MRF Imaging
Description: IVIM imaging will be performed to evaluate microstructural and perfusion changes in the salivary glands of nasopharyngeal carcinoma patients undergoing radiotherapy. This technique quantifies diffusion and perfusion parameters, providing insights into early tissue damage.~MRF imaging will be used to quantify salivary gland tissue characteristics, including relaxation parameters (T1 and T2 mapping), to monitor radiotherapy-induced damage. The technique enables precise tissue characterization through multi-parametric MRI.
Study NCT06750250 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient education
Description: The group A will be Education and Self-Management. Patient Education: Providing information on the benefits of physical activity, proper exercise techniques, and self-care strategies.~Self-Management Programs: Empowering women to take an active role in managing their health and fitness. Frequency: 3 session/ month, Intensity: Mild to moderate, Type: Walking Time: 30 to 45mints /sessions
Study NCT06750250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobics
Description: Treadmill: A manual Treadmill intervention involves moderate-intensity aerobic exercise on a treadmill for 15 minute with the heart rate gradually reaching 75-85% of the maximum. Training frequency was not specified. It significantly reduced menstrual pain intensity 3 session per month. Stationary Bicycling: Start with gentle, low-intensity cycling and gradually increase as comfort allow the duration of exercise 10 mints per month. Running : The running is a low intensity effort of short to moderate duration 10 to 15 mints per mile
Study NCT05141799 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: high intensity laser therapy
Description: Laser treatment is noninvasive and painless and can be easily administered in therapy units for a wide range of conditions. High-intensity laser therapy (HILT) has gained importance for the treatment of different kinds of sports injuries such as tendon injuries, contusions, and muscle spasms.
Study NCT05141799 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: high intensity laser therapy
Description: Laser treatment is noninvasive and painless and can be easily administered in therapy units for a wide range of conditions. High-intensity laser therapy (HILT) has gained importance for the treatment of different kinds of sports injuries such as tendon injuries, contusions, and muscle spasms.
Study NCT06768788 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Face-to-face and web-based need-supportive intervention program based on the main tenets of SDT in the field of PE 1
Description: Intervention: need support, two-month face-to-face and web-based need-supportive intervention program for PE teachers.
Study NCT06768788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face-to-face and web-based need-supportive intervention program based on the main tenets of SDT in the field of PE 1
Description: Intervention: need support, two-month face-to-face and web-based need-supportive intervention program for PE teachers.
Study NCT06768788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face-to-face and web-based need-supportive intervention program based on the main tenets of SDT in the field of PE 2
Description: Intervention: autonomy or competence or relatedness support, one-month face-to-face and web-based need-supportive intervention program for PE teachers.
Study NCT06768788 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Face-to-face and web-based need-supportive intervention program based on the main tenets of SDT in the field of PE 2
Description: Intervention: autonomy or competence or relatedness support, one-month face-to-face and web-based need-supportive intervention program for PE teachers.
Study NCT06771544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT06771544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given PO
Study NCT06771050 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Debridement and Implant Retention (DAIR)
Description: Intervention 1: DAIR- cleaning of infected joint including irrigation, debridement and exchange of modular components (those not fixed to bone) with implant retention.~Intervention 2: Single stage revision - cleaning of infected joint including irrigation, removal and placement of definitive new components which could be primary or revision components.
Study NCT06771050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic Choice
Description: No intervention: Backbone antibiotic therapy only depends on the organism and is detailed in the protocol.~Intervention: Backbone antibiotic therapy plus rifampicin. Dosage 600-900mg per day orally for as long as oral antibiotic treatment continues, but not more than 12 weeks. Prescribed according to local recommended practices and dosed as per local therapeutic guidelines.
Study NCT06771050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic duration Part A - Single stage revision
Description: Intervention Arm: Short course 6-week (42 +/- 7 days) antibiotic course - combined intravenous and oral with antibiotic choice according to organism and patient tolerability factors.~Intervention Arm: Long course 12- week (84 +/- 7 days) antibiotic course - combined intravenous and oral with antibiotic choice according to organism and patient tolerability factors.
Study NCT06771050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic Duration Part B - Two stage revision
Description: Intervention Arm: Extended prophylaxis for 12 weeks after the 2nd stage revision surgery.~Intervention Arm: No extended antibiotic prophylaxis after the 2nd stage revision surgery.~Antibiotic choice by treating team with reference to the original causative organism(s), susceptibility and patient tolerability.
Study NCT06772285 — intervention group
Intervention type: OTHER
Intervention: Albert Health app
Description: Test an existing digital health app, called Albert Health, designed to support patients with a newly inserted feeding tube to use and manage their tube care, in a feasibility study.
Study NCT06773728 — intervention group
Intervention type: DEVICE
Intervention: Record occlusal contacts
Description: Register using a digital device (t-scan) the occlusal contacts
Study NCT06773728 — intervention group
Intervention type: DEVICE
Intervention: Tracking of jaw movement
Description: An optical jaw tracking system (Modjaw, Modjaw) is going to be implemented
Study NCT06773728 — intervention group
Intervention type: DEVICE
Intervention: Tracking of jaw movement
Description: Jaw tracking will be performed using an optical jaw tracking system (Zebris, Zebris medical)
Study NCT06770530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: 400 mg inravenous Fluconazole, single dose 200 ml
Study NCT06770530 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline solution
Description: Intravenous saline solution, single dose 200 ml
Study NCT06772636 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: music group
Description: In the music group, the music chosen by the participant will be played through a speaker by the nursing staff during outpatient hysteroscopy. Music will be played through a speaker instead of headphones in order to maintain good communication and interaction between the participant and the doctor.
Study NCT06772636 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: non music group
Description: Participants in the non-music group will undergo hysterosalpingography in the same setting and standard procedure without listening to any music.